# Breathe BioMedical Launches Second Site in Multi-Center Breast Cancer Breath Test Trial at Duke University

> clinical trial · REPORTED · 2025-06-17

Breathe BioMedical opened Duke University in Durham, NC as the second site in its large multi-center observational study to validate its non-invasive breath test for early breast cancer detection in women with dense breast tissue, as an adjunct to mammography. The trial is co-led by Mayo Clinic investigators and aims to identify breath-based VOC biomarkers of cancer.

- Company: Breathe Biomedical
- Sector: diagnostics
- Primary source: https://breathebiomedical.com/breathe-biomedical-launches-second-site-in-its-multi-center-clinical-trial-of-its-breath-test-for-breast-cancer/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.